社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Ruixiang
IP属地：未知
+关注
帖子 · 200
帖子 · 200
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Ruixiang
Ruixiang
·
2021-12-09
Q
Airline stocks dropped in morning trading
Airline stocks dropped in morning trading.American Airlines to reduce international flights due to B
Airline stocks dropped in morning trading
看
2,470
回复
2
点赞
8
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-12-07
W
非常抱歉，此主贴已删除
看
1,978
回复
2
点赞
5
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-12-03
Q
Apple Learns the Hard Way That Fewer People Want Its New iPhones
An iPhone a year keeps the customers away. That's a stark new lesson for Apple, which reportedly tol
Apple Learns the Hard Way That Fewer People Want Its New iPhones
看
2,341
回复
2
点赞
5
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-12-02
Q
非常抱歉，此主贴已删除
看
1,728
回复
1
点赞
3
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-12-01
Q
Regeneron's COVID-19 antibody drug may be less effective against Omicron
Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag
Regeneron's COVID-19 antibody drug may be less effective against Omicron
看
1,868
回复
1
点赞
4
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-11-30
Q
非常抱歉，此主贴已删除
看
2,057
回复
2
点赞
2
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-11-29
Q
November jobs report: What to know this week
As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor
November jobs report: What to know this week
看
1,632
回复
评论
点赞
4
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-11-28
A
非常抱歉，此主贴已删除
看
2,111
回复
4
点赞
4
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-11-26
Q
非常抱歉，此主贴已删除
看
2,410
回复
1
点赞
2
编组 21备份 2
分享
举报
Ruixiang
Ruixiang
·
2021-11-25
Q
非常抱歉，此主贴已删除
看
1,669
回复
1
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3573100524668837","uuid":"3573100524668837","gmtCreate":1610069534371,"gmtModify":1622341810701,"name":"Ruixiang","pinyin":"ruixiang","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":16,"headSize":388,"tweetSize":200,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.15","exceedPercentage":"80.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602454365,"gmtCreate":1639060978663,"gmtModify":1639061468586,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602454365","repostId":"1127031777","repostType":4,"repost":{"id":"1127031777","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639060579,"share":"https://www.laohu8.com/m/news/1127031777?lang=&edition=full","pubTime":"2021-12-09 22:36","market":"us","language":"en","title":"Airline stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1127031777","media":"Tiger Newspress","summary":"Airline stocks dropped in morning trading.American Airlines to reduce international flights due to B","content":"<p>Airline stocks dropped in morning trading.American Airlines to reduce international flights due to Boeing Dreamliner delays.</p>\n<p><img src=\"https://static.tigerbbs.com/327595ca83ef0e199f89e99f0e55faf4\" tg-width=\"417\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>American Airlines Group Inc. is planning to trim international flights next summer because of Boeing Co.’s delays in delivering new 787 Dreamliners, according to people familiar with the matter and a draft internal airline memo.</p>\n<p>A schedule cut by the world’s largest carrier by passenger traffic is the latest sign of broader fallout for Boeing’s prolonged Dreamliner production problems that have largely prevented it from handing over the popular wide-body jets to airlines for more than a year.</p>\n<p>American won’t fly to Edinburgh; Shannon, Ireland; or Hong Kong next summer, and will reduce the frequency of flights to Shanghai, Beijing and Sydney, according to the memo viewed by The Wall Street Journal. The carrier isn’t bringing back seasonal flights to Prague or Dubrovnik, Croatia, and it is delaying the launch of certain routes, such as from Seattle to Bangalore, India, which it had announced before the pandemic hit.</p>\n<p>“Without these wide-bodies, we simply won’t be able to fly as much internationally as we had planned next summer, or as we did in summer 2019,” Vasu Raja, American’s chief revenue officer, wrote in the draft internal memo.</p>\n<p><img src=\"https://static.tigerbbs.com/edb980d2c5e286a64cdcfd2c89dedfe2\" tg-width=\"1050\" tg-height=\"701\" referrerpolicy=\"no-referrer\"></p>\n<p>A Boeing spokesman said the plane maker deeply regrets “the impact to our customers as we work through the process to resume deliveries of new 787s.”</p>\n<p>Deliveries are expected to resume by April 1, 2022, at the earliest, later than previously anticipated, according to people familiar with the matter.</p>\n<p>Airlines’ summer schedules aren’t final yet, and carriers may consider other factors such as reduced demand due to the latest coronavirus variants and lingering travel restrictions in deciding which markets to serve. Long-haul international travel has been the slowest to bounce back since the onset of the pandemic, and airline executives have said they expect pent-up demand to fuel a surge in bookings next summer.</p>\n<p>United Airlines Holdings Inc.,another U.S. operator of Dreamliners, had been expecting eight new 787s to arrive in the last half of 2021, according to a July securities filing. A spokeswoman said the Chicago-based carrier is working closely with Boeing to understand how the delivery delays may affect its schedule.</p>\n<p>Fort Worth, Texas-based American had initially planned to offer a summer 2022 schedule with 89% of the long-haul international flying it had pre-pandemic, according to a person familiar with the airline’s plans. Instead, this person said, American is expected to fly 80% as much on such routes as it did during summer 2019 because it doesn’t have enough wide-body aircraft due to the delayed Boeing deliveries.</p>\n<p>According to the memo, American is planning to maintain its presence in Mexico, the Caribbean and Latin America; fly a full schedule to London, Dublin and Madrid; and add a route between New York and Doha, Qatar.</p>\n<p>American had been betting on Boeing’s Dreamliners to help lift the airline out of the depths of the pandemic. Early last year, as governments world-wide imposed travel restrictions and airlines canceled international flights, American accelerated planned retirements of its aging wide-body Boeing and Airbus aircraft. It received one new Dreamliner during a brief resumption of deliveries earlier this year and, according to a July securities filing, had been expecting 11 by the year’s end. It isn’t clear when they will arrive, people familiar with the matter said.</p>\n<p>Ever since halting Dreamliner deliveries in October 2020, Boeing has been dealing with various production defects. For much of this year, the company has been seeking approval from U.S. aviation regulators for pre-delivery inspections.</p>\n<p>Earlier this year, Boeing slowed production, and then additional problems further bogged down its North Charleston, S.C., factory. The undelivered inventory, in excess of 100 Dreamliners, is worth more than $25 billion.</p>\n<p>The Boeing spokesman said the manufacturer continued to conduct inspections and repairs as needed on undelivered 787s, aiming to take the “time needed to ensure conformance to our exacting specifications” while regulators review the company’s processes.</p>\n<p>Boeing’s production issues have also spilled over to its suppliers. Italian aerospace manufacturer Leonardo SpA is planning to furlough for about three months early next year some 1,000 employees in southern Italy who make Dreamliner fuselage sections, a company spokesman said. The furloughs were earlier reported by Reuters.</p>\n<p>By April 1, Boeing is estimated to have as many as 66 built Dreamliners at risk of cancellation under aircraft purchasing contracts that generally allow buyers to walk away without penalty if deliveries are a year late, according to aviation data provider Ascend by Cirium. The plane maker has begun reaching out to potential customers to gauge interest in Dreamliners originally built for different customers, a person familiar with the matter said.</p>\n<p>Earlier this fall, American executives suggested in a call with their Boeing counterparts that the carrier could walk away from at least some undelivered aircraft, according to people familiar with the conversation.</p>\n<p>Boeing CEO David Calhoun and his commercial unit chief Stan Deal called American President Robert Isom, slated to be the carrier’s next chief executive, more recently to assure him the manufacturer would fully compensate American for the delays, one of these people said.</p>\n<p>American’s Mr. Raja, in his draft internal memo, said the airline still has “great confidence in the Dreamliner” and would continue working with Boeing on deliveries.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Airline stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAirline stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Airline stocks dropped in morning trading.American Airlines to reduce international flights due to Boeing Dreamliner delays.</p>\n<p><img src=\"https://static.tigerbbs.com/327595ca83ef0e199f89e99f0e55faf4\" tg-width=\"417\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>American Airlines Group Inc. is planning to trim international flights next summer because of Boeing Co.’s delays in delivering new 787 Dreamliners, according to people familiar with the matter and a draft internal airline memo.</p>\n<p>A schedule cut by the world’s largest carrier by passenger traffic is the latest sign of broader fallout for Boeing’s prolonged Dreamliner production problems that have largely prevented it from handing over the popular wide-body jets to airlines for more than a year.</p>\n<p>American won’t fly to Edinburgh; Shannon, Ireland; or Hong Kong next summer, and will reduce the frequency of flights to Shanghai, Beijing and Sydney, according to the memo viewed by The Wall Street Journal. The carrier isn’t bringing back seasonal flights to Prague or Dubrovnik, Croatia, and it is delaying the launch of certain routes, such as from Seattle to Bangalore, India, which it had announced before the pandemic hit.</p>\n<p>“Without these wide-bodies, we simply won’t be able to fly as much internationally as we had planned next summer, or as we did in summer 2019,” Vasu Raja, American’s chief revenue officer, wrote in the draft internal memo.</p>\n<p><img src=\"https://static.tigerbbs.com/edb980d2c5e286a64cdcfd2c89dedfe2\" tg-width=\"1050\" tg-height=\"701\" referrerpolicy=\"no-referrer\"></p>\n<p>A Boeing spokesman said the plane maker deeply regrets “the impact to our customers as we work through the process to resume deliveries of new 787s.”</p>\n<p>Deliveries are expected to resume by April 1, 2022, at the earliest, later than previously anticipated, according to people familiar with the matter.</p>\n<p>Airlines’ summer schedules aren’t final yet, and carriers may consider other factors such as reduced demand due to the latest coronavirus variants and lingering travel restrictions in deciding which markets to serve. Long-haul international travel has been the slowest to bounce back since the onset of the pandemic, and airline executives have said they expect pent-up demand to fuel a surge in bookings next summer.</p>\n<p>United Airlines Holdings Inc.,another U.S. operator of Dreamliners, had been expecting eight new 787s to arrive in the last half of 2021, according to a July securities filing. A spokeswoman said the Chicago-based carrier is working closely with Boeing to understand how the delivery delays may affect its schedule.</p>\n<p>Fort Worth, Texas-based American had initially planned to offer a summer 2022 schedule with 89% of the long-haul international flying it had pre-pandemic, according to a person familiar with the airline’s plans. Instead, this person said, American is expected to fly 80% as much on such routes as it did during summer 2019 because it doesn’t have enough wide-body aircraft due to the delayed Boeing deliveries.</p>\n<p>According to the memo, American is planning to maintain its presence in Mexico, the Caribbean and Latin America; fly a full schedule to London, Dublin and Madrid; and add a route between New York and Doha, Qatar.</p>\n<p>American had been betting on Boeing’s Dreamliners to help lift the airline out of the depths of the pandemic. Early last year, as governments world-wide imposed travel restrictions and airlines canceled international flights, American accelerated planned retirements of its aging wide-body Boeing and Airbus aircraft. It received one new Dreamliner during a brief resumption of deliveries earlier this year and, according to a July securities filing, had been expecting 11 by the year’s end. It isn’t clear when they will arrive, people familiar with the matter said.</p>\n<p>Ever since halting Dreamliner deliveries in October 2020, Boeing has been dealing with various production defects. For much of this year, the company has been seeking approval from U.S. aviation regulators for pre-delivery inspections.</p>\n<p>Earlier this year, Boeing slowed production, and then additional problems further bogged down its North Charleston, S.C., factory. The undelivered inventory, in excess of 100 Dreamliners, is worth more than $25 billion.</p>\n<p>The Boeing spokesman said the manufacturer continued to conduct inspections and repairs as needed on undelivered 787s, aiming to take the “time needed to ensure conformance to our exacting specifications” while regulators review the company’s processes.</p>\n<p>Boeing’s production issues have also spilled over to its suppliers. Italian aerospace manufacturer Leonardo SpA is planning to furlough for about three months early next year some 1,000 employees in southern Italy who make Dreamliner fuselage sections, a company spokesman said. The furloughs were earlier reported by Reuters.</p>\n<p>By April 1, Boeing is estimated to have as many as 66 built Dreamliners at risk of cancellation under aircraft purchasing contracts that generally allow buyers to walk away without penalty if deliveries are a year late, according to aviation data provider Ascend by Cirium. The plane maker has begun reaching out to potential customers to gauge interest in Dreamliners originally built for different customers, a person familiar with the matter said.</p>\n<p>Earlier this fall, American executives suggested in a call with their Boeing counterparts that the carrier could walk away from at least some undelivered aircraft, according to people familiar with the conversation.</p>\n<p>Boeing CEO David Calhoun and his commercial unit chief Stan Deal called American President Robert Isom, slated to be the carrier’s next chief executive, more recently to assure him the manufacturer would fully compensate American for the delays, one of these people said.</p>\n<p>American’s Mr. Raja, in his draft internal memo, said the airline still has “great confidence in the Dreamliner” and would continue working with Boeing on deliveries.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAL":"美国航空","SAVE":"Spirit Airlines","LUV":"西南航空","BA":"波音","JBLU":"捷蓝航空","UAL":"联合大陆航空","DAL":"达美航空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127031777","content_text":"Airline stocks dropped in morning trading.American Airlines to reduce international flights due to Boeing Dreamliner delays.\n\nAmerican Airlines Group Inc. is planning to trim international flights next summer because of Boeing Co.’s delays in delivering new 787 Dreamliners, according to people familiar with the matter and a draft internal airline memo.\nA schedule cut by the world’s largest carrier by passenger traffic is the latest sign of broader fallout for Boeing’s prolonged Dreamliner production problems that have largely prevented it from handing over the popular wide-body jets to airlines for more than a year.\nAmerican won’t fly to Edinburgh; Shannon, Ireland; or Hong Kong next summer, and will reduce the frequency of flights to Shanghai, Beijing and Sydney, according to the memo viewed by The Wall Street Journal. The carrier isn’t bringing back seasonal flights to Prague or Dubrovnik, Croatia, and it is delaying the launch of certain routes, such as from Seattle to Bangalore, India, which it had announced before the pandemic hit.\n“Without these wide-bodies, we simply won’t be able to fly as much internationally as we had planned next summer, or as we did in summer 2019,” Vasu Raja, American’s chief revenue officer, wrote in the draft internal memo.\n\nA Boeing spokesman said the plane maker deeply regrets “the impact to our customers as we work through the process to resume deliveries of new 787s.”\nDeliveries are expected to resume by April 1, 2022, at the earliest, later than previously anticipated, according to people familiar with the matter.\nAirlines’ summer schedules aren’t final yet, and carriers may consider other factors such as reduced demand due to the latest coronavirus variants and lingering travel restrictions in deciding which markets to serve. Long-haul international travel has been the slowest to bounce back since the onset of the pandemic, and airline executives have said they expect pent-up demand to fuel a surge in bookings next summer.\nUnited Airlines Holdings Inc.,another U.S. operator of Dreamliners, had been expecting eight new 787s to arrive in the last half of 2021, according to a July securities filing. A spokeswoman said the Chicago-based carrier is working closely with Boeing to understand how the delivery delays may affect its schedule.\nFort Worth, Texas-based American had initially planned to offer a summer 2022 schedule with 89% of the long-haul international flying it had pre-pandemic, according to a person familiar with the airline’s plans. Instead, this person said, American is expected to fly 80% as much on such routes as it did during summer 2019 because it doesn’t have enough wide-body aircraft due to the delayed Boeing deliveries.\nAccording to the memo, American is planning to maintain its presence in Mexico, the Caribbean and Latin America; fly a full schedule to London, Dublin and Madrid; and add a route between New York and Doha, Qatar.\nAmerican had been betting on Boeing’s Dreamliners to help lift the airline out of the depths of the pandemic. Early last year, as governments world-wide imposed travel restrictions and airlines canceled international flights, American accelerated planned retirements of its aging wide-body Boeing and Airbus aircraft. It received one new Dreamliner during a brief resumption of deliveries earlier this year and, according to a July securities filing, had been expecting 11 by the year’s end. It isn’t clear when they will arrive, people familiar with the matter said.\nEver since halting Dreamliner deliveries in October 2020, Boeing has been dealing with various production defects. For much of this year, the company has been seeking approval from U.S. aviation regulators for pre-delivery inspections.\nEarlier this year, Boeing slowed production, and then additional problems further bogged down its North Charleston, S.C., factory. The undelivered inventory, in excess of 100 Dreamliners, is worth more than $25 billion.\nThe Boeing spokesman said the manufacturer continued to conduct inspections and repairs as needed on undelivered 787s, aiming to take the “time needed to ensure conformance to our exacting specifications” while regulators review the company’s processes.\nBoeing’s production issues have also spilled over to its suppliers. Italian aerospace manufacturer Leonardo SpA is planning to furlough for about three months early next year some 1,000 employees in southern Italy who make Dreamliner fuselage sections, a company spokesman said. The furloughs were earlier reported by Reuters.\nBy April 1, Boeing is estimated to have as many as 66 built Dreamliners at risk of cancellation under aircraft purchasing contracts that generally allow buyers to walk away without penalty if deliveries are a year late, according to aviation data provider Ascend by Cirium. The plane maker has begun reaching out to potential customers to gauge interest in Dreamliners originally built for different customers, a person familiar with the matter said.\nEarlier this fall, American executives suggested in a call with their Boeing counterparts that the carrier could walk away from at least some undelivered aircraft, according to people familiar with the conversation.\nBoeing CEO David Calhoun and his commercial unit chief Stan Deal called American President Robert Isom, slated to be the carrier’s next chief executive, more recently to assure him the manufacturer would fully compensate American for the delays, one of these people said.\nAmerican’s Mr. Raja, in his draft internal memo, said the airline still has “great confidence in the Dreamliner” and would continue working with Boeing on deliveries.","news_type":1,"symbols_score_info":{"AAL":0.9,"BA":0.9,"DAL":0.9,"JBLU":0.9,"LUV":0.9,"SAVE":0.9,"UAL":0.9}},"isVote":1,"tweetType":1,"viewCount":2470,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606686364,"gmtCreate":1638871600242,"gmtModify":1638871600445,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"W","listText":"W","text":"W","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606686364","repostId":"1178174926","repostType":4,"isVote":1,"tweetType":1,"viewCount":1978,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601173791,"gmtCreate":1638502364414,"gmtModify":1638502364544,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601173791","repostId":"1129439866","repostType":4,"repost":{"id":"1129439866","kind":"news","pubTimestamp":1638502156,"share":"https://www.laohu8.com/m/news/1129439866?lang=&edition=full","pubTime":"2021-12-03 11:29","market":"us","language":"en","title":"Apple Learns the Hard Way That Fewer People Want Its New iPhones","url":"https://stock-news.laohu8.com/highlight/detail?id=1129439866","media":"Motley Fool","summary":"An iPhone a year keeps the customers away.\nThat's a stark new lesson for Apple, which reportedly tol","content":"<p>An iPhone a year keeps the customers away.</p>\n<p>That's a stark new lesson for Apple, which reportedly told its suppliers this week that demand for its brand new iPhone 13 is falling in advance of the holidays. With a mix of customer fatigue and economic uncertainty, there's no sign of demand ticking up in the New Year, either.</p>\n<p>Slumping Demand Still Means Record Profits</p>\n<p>Every year, Apple hosts rock concert style events where its new products debut to tech consumer fanfare unlike any other — turning the launch of new phones into a cultural event as much as a business one. But this year's iPhone 13 wasn't exactly world shattering, featuring only some minor upgrades to processing power and camera functions.</p>\n<p>That doesn't appear to have cut it. According to sources who spoke to <i>Bloomberg</i>, the tech giant has begun notifying suppliers that some of their orders may never materialize, months after it already cut production numbers due to supply chain woes:</p>\n<ul>\n <li>Before the demand slump, Apple already slashed its 2021 production target for iPhone 13 down 10 million units, down to 90 million total because not enough parts were available.</li>\n <li>There's still no need to spare sympathy for Tim Cook and Co: even with demand trending downward, Apple is on pace for a record $117.9 billion in sales in the final three months of 2021, according to Wall Street analysts — they'll have to settle for a less gigantic quarter than expected.</li>\n</ul>\n<p><b>Haters Gonna Hate:</b> Apple shares fell over 3% in early trading Thursday, but one analyst was emphatic that present concerns are a big fat nothing. \"The haters will continue to hate on Apple, but we believe a $3 trillion market cap is in the crystal ball despite these negative white knuckle headlines worrying the Street,\" Wedbush securities managing director Dan Ives told the<i>New York Post</i>.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Learns the Hard Way That Fewer People Want Its New iPhones</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Learns the Hard Way That Fewer People Want Its New iPhones\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 11:29 GMT+8 <a href=https://www.fool.com/investing/2021/12/02/apple-learns-the-hard-way-that-fewer-people-want-i/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An iPhone a year keeps the customers away.\nThat's a stark new lesson for Apple, which reportedly told its suppliers this week that demand for its brand new iPhone 13 is falling in advance of the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/02/apple-learns-the-hard-way-that-fewer-people-want-i/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/12/02/apple-learns-the-hard-way-that-fewer-people-want-i/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129439866","content_text":"An iPhone a year keeps the customers away.\nThat's a stark new lesson for Apple, which reportedly told its suppliers this week that demand for its brand new iPhone 13 is falling in advance of the holidays. With a mix of customer fatigue and economic uncertainty, there's no sign of demand ticking up in the New Year, either.\nSlumping Demand Still Means Record Profits\nEvery year, Apple hosts rock concert style events where its new products debut to tech consumer fanfare unlike any other — turning the launch of new phones into a cultural event as much as a business one. But this year's iPhone 13 wasn't exactly world shattering, featuring only some minor upgrades to processing power and camera functions.\nThat doesn't appear to have cut it. According to sources who spoke to Bloomberg, the tech giant has begun notifying suppliers that some of their orders may never materialize, months after it already cut production numbers due to supply chain woes:\n\nBefore the demand slump, Apple already slashed its 2021 production target for iPhone 13 down 10 million units, down to 90 million total because not enough parts were available.\nThere's still no need to spare sympathy for Tim Cook and Co: even with demand trending downward, Apple is on pace for a record $117.9 billion in sales in the final three months of 2021, according to Wall Street analysts — they'll have to settle for a less gigantic quarter than expected.\n\nHaters Gonna Hate: Apple shares fell over 3% in early trading Thursday, but one analyst was emphatic that present concerns are a big fat nothing. \"The haters will continue to hate on Apple, but we believe a $3 trillion market cap is in the crystal ball despite these negative white knuckle headlines worrying the Street,\" Wedbush securities managing director Dan Ives told theNew York Post.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603559119,"gmtCreate":1638431085226,"gmtModify":1638431085512,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603559119","repostId":"2188594373","repostType":4,"isVote":1,"tweetType":1,"viewCount":1728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609757217,"gmtCreate":1638331088047,"gmtModify":1638331088135,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609757217","repostId":"1101502249","repostType":4,"repost":{"id":"1101502249","kind":"news","pubTimestamp":1638330314,"share":"https://www.laohu8.com/m/news/1101502249?lang=&edition=full","pubTime":"2021-12-01 11:45","market":"us","language":"en","title":"Regeneron's COVID-19 antibody drug may be less effective against Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1101502249","media":"Reuters","summary":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag","content":"<p>Nov 30 (Reuters) - <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.</p>\n<p>Global markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.</p>\n<p>Based on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.</p>\n<p>The company said it was doing further study to quantify the potential impact using the variant's genetic sequence.</p>\n<p>One of the antibodies used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.</p>\n<p>\"<a href=\"https://laohu8.com/S/JE\">Just</a> like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"</p>\n<p><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.</p>\n<p>Regeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.</p>\n<p>Rival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.</p>\n<p>The company is \"working to confirm this in the lab as a matter of urgency\", it added.</p>\n<p>Gilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron</p>\n<p>The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron's COVID-19 antibody drug may be less effective against Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron's COVID-19 antibody drug may be less effective against Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 11:45 GMT+8 <a href=https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after ...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司","MRNA":"Moderna, Inc.","LLY":"礼来","GILD":"吉利德科学"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101502249","content_text":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.\nGlobal markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.\nBased on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.\nThe company said it was doing further study to quantify the potential impact using the variant's genetic sequence.\nOne of the antibodies used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.\n\"Just like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"\nEli Lilly and Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.\nRegeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.\nRival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.\nThe company is \"working to confirm this in the lab as a matter of urgency\", it added.\nGilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron\nThe U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.","news_type":1,"symbols_score_info":{"GILD":0.9,"LLY":0.9,"MRNA":0.9,"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609831470,"gmtCreate":1638262376725,"gmtModify":1638262376815,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609831470","repostId":"1142721277","repostType":4,"isVote":1,"tweetType":1,"viewCount":2057,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600210934,"gmtCreate":1638155685573,"gmtModify":1638155685666,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600210934","repostId":"1124072014","repostType":4,"repost":{"id":"1124072014","kind":"news","pubTimestamp":1638140765,"share":"https://www.laohu8.com/m/news/1124072014?lang=&edition=full","pubTime":"2021-11-29 07:06","market":"us","language":"en","title":"November jobs report: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1124072014","media":"yahoo","summary":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor","content":"<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.</p>\n<p>The Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.</p>\n<p>\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.</p>\n<p>\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply could<i>worsen</i>over the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"</p>\n<p>On a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.</p>\n<p>Growing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.</p>\n<p>Other recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.</p>\n<p>Even given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.</p>\n<p>Returning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.</p>\n<p>\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"</p>\n<p>Economic calendar</p>\n<ul>\n <li><p><b>Monday:</b>Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)</p></li>\n <li><p><b>Tuesday:</b>FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)</p></li>\n <li><p><b>Wednesday:</b>MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book</p></li>\n <li><p><b>Thursday:</b>Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)</p></li>\n <li><p><b>Friday:</b>Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)</p></li>\n</ul>\n<p>Earnings calendar</p>\n<ul>\n <li><p><b>Monday:</b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday:</b>Salesforce.com (CRM) after market close</p></li>\n <li><p><b>Wednesday:</b>PVH Corp. (PVH) after market close</p></li>\n <li><p><b>Thursday:</b>Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close</p></li>\n <li><p><b>Friday:</b><i>No notable reports scheduled for release</i></p></li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>November jobs report: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovember jobs report: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 07:06 GMT+8 <a href=https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html><strong>yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124072014","content_text":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.\n\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.\n\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply couldworsenover the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"\nOn a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.\nGrowing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.\nOther recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.\nEven given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.\nReturning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.\n\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"\nEconomic calendar\n\nMonday:Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)\nTuesday:FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)\nWednesday:MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book\nThursday:Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)\nFriday:Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)\n\nEarnings calendar\n\nMonday:No notable reports scheduled for release\nTuesday:Salesforce.com (CRM) after market close\nWednesday:PVH Corp. (PVH) after market close\nThursday:Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close\nFriday:No notable reports scheduled for release","news_type":1,"symbols_score_info":{"CRM":0.9}},"isVote":1,"tweetType":1,"viewCount":1632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600370776,"gmtCreate":1638075858692,"gmtModify":1638075858812,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"A","listText":"A","text":"A","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600370776","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":2111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877358367,"gmtCreate":1637891050426,"gmtModify":1637891050579,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877358367","repostId":"1170160309","repostType":4,"isVote":1,"tweetType":1,"viewCount":2410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874551236,"gmtCreate":1637803998526,"gmtModify":1637803998654,"author":{"id":"3573100524668837","authorId":"3573100524668837","name":"Ruixiang","avatar":"https://static.tigerbbs.com/7f71da180ee0c8214a37155cd6d7f87c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573100524668837","authorIdStr":"3573100524668837"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874551236","repostId":"2186363038","repostType":4,"isVote":1,"tweetType":1,"viewCount":1669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}